AXA Framlington Biotech Fund GBP Z Acc

Register to Unlock Ratings
Morningstar Rating™(Relative to Category)31/08/2021
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearHighAverage4 star
5-YearAbove AverageAverage4 star
10-Year*HighAbove Average5 star
Overall*HighAbove Average5 star
Click here to see our Methodology
1 Year Daily Volatility Chart (annualised)
  • AXA Framlington Biotech Fund GBP Z Acc
  • NASDAQ Biotechnology TR USD
Volatility Measurements31/08/2021
3-Yr Std Dev21.86 %
3-Yr Mean Return12.80 %
3-Yr Sharpe Ratio0.53
Modern Portfolio Statistics31/08/202131/08/2021
 Standard IndexBest Fit Index
 NASDAQ Biotechnology TR USD  NASDAQ Biotechnology PR USD
3-Yr Beta0.950.95
3-Yr Alpha0.881.43
* This share class has performance data calculated prior to the inception date, 2012-04-16. This is based upon a simulated/extended track record, using the track record of AXA Framlington Biotech R Acc (ISIN: GB0031007254), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement